PH13130A - Pharmaceutical composition and method - Google Patents
Pharmaceutical composition and methodInfo
- Publication number
- PH13130A PH13130A PH20533A PH20533A PH13130A PH 13130 A PH13130 A PH 13130A PH 20533 A PH20533 A PH 20533A PH 20533 A PH20533 A PH 20533A PH 13130 A PH13130 A PH 13130A
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/751,830 US4067983A (en) | 1976-12-17 | 1976-12-17 | Pharmaceutical compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH13130A true PH13130A (en) | 1979-12-12 |
Family
ID=25023676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH20533A PH13130A (en) | 1976-12-17 | 1977-12-09 | Pharmaceutical composition and method |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4067983A (ja) |
| JP (1) | JPS5953884B2 (ja) |
| AU (1) | AU514828B2 (ja) |
| BE (1) | BE861648A (ja) |
| CA (1) | CA1087987A (ja) |
| DE (1) | DE2755017A1 (ja) |
| FR (1) | FR2374036A1 (ja) |
| GB (1) | GB1560247A (ja) |
| HK (1) | HK3984A (ja) |
| IL (1) | IL53578A (ja) |
| NZ (1) | NZ185928A (ja) |
| PH (1) | PH13130A (ja) |
| ZA (1) | ZA777358B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4371537A (en) * | 1981-08-13 | 1983-02-01 | The Dow Chemical Company | Sulfur-substituted phenoxypyridines having antiviral activity |
| US4434169A (en) * | 1983-01-03 | 1984-02-28 | Warner-Lambert Company | Pharmaceutical compositions and methods |
| US4666926A (en) * | 1986-02-27 | 1987-05-19 | Warner-Lambert Company | Transdermal formulations |
| US5232934A (en) * | 1992-07-17 | 1993-08-03 | Warner-Lambert Co. | Method for the treatment of psychomotor stimulant addiction |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH434868A (de) * | 1964-02-10 | 1967-04-30 | Ciba Geigy | Schädlingsbekämpfungsmittel |
-
1976
- 1976-12-17 US US05/751,830 patent/US4067983A/en not_active Expired - Lifetime
-
1977
- 1977-12-08 BE BE183290A patent/BE861648A/xx not_active IP Right Cessation
- 1977-12-09 IL IL53578A patent/IL53578A/xx unknown
- 1977-12-09 GB GB51442/77A patent/GB1560247A/en not_active Expired
- 1977-12-09 AU AU31415/77A patent/AU514828B2/en not_active Expired
- 1977-12-09 JP JP52147322A patent/JPS5953884B2/ja not_active Expired
- 1977-12-09 DE DE19772755017 patent/DE2755017A1/de active Granted
- 1977-12-09 ZA ZA00777358A patent/ZA777358B/xx unknown
- 1977-12-09 FR FR7737158A patent/FR2374036A1/fr active Granted
- 1977-12-09 PH PH20533A patent/PH13130A/en unknown
- 1977-12-09 NZ NZ185928A patent/NZ185928A/en unknown
- 1977-12-09 CA CA292,755A patent/CA1087987A/en not_active Expired
-
1984
- 1984-01-12 HK HK39/84A patent/HK3984A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA777358B (en) | 1979-07-25 |
| FR2374036A1 (fr) | 1978-07-13 |
| GB1560247A (en) | 1980-01-30 |
| HK3984A (en) | 1984-01-20 |
| JPS5379038A (en) | 1978-07-13 |
| NZ185928A (en) | 1984-05-31 |
| DE2755017C2 (ja) | 1988-02-04 |
| IL53578A0 (en) | 1978-03-10 |
| US4067983A (en) | 1978-01-10 |
| DE2755017A1 (de) | 1978-06-29 |
| BE861648A (fr) | 1978-03-31 |
| IL53578A (en) | 1980-11-30 |
| JPS5953884B2 (ja) | 1984-12-27 |
| FR2374036B1 (ja) | 1980-03-14 |
| AU3141577A (en) | 1979-06-14 |
| AU514828B2 (en) | 1981-02-26 |
| CA1087987A (en) | 1980-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5223064A (en) | Composition and method | |
| JPS54135776A (en) | Pharmaceutical composition and method | |
| ZA771998B (en) | Triazolo-pyrimidines and pharmaceutical compositions containing them | |
| JPS5295644A (en) | Composition and method | |
| NZ185986A (en) | 2-oxa-bicyclic prostag-landins and pharmaceutical compositions | |
| JPS52122619A (en) | Pourron type anthelmintic composition and method | |
| NZ185356A (en) | 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them | |
| NZ183551A (en) | Aminochromanols and pharmaceutical compositions containingthem | |
| GR63609B (en) | Method for dimethyloether preparation and catalyte therein | |
| NZ185358A (en) | Spiro-hydantoins and pharmaceutical compositions | |
| JPS53139730A (en) | Pharmaceutical composition and method | |
| JPS5219670A (en) | Chromann44ons and preparation method thereof | |
| NZ183134A (en) | I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions | |
| NZ184428A (en) | N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions | |
| IL52433A (en) | 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them | |
| JPS532464A (en) | Composition and method | |
| NZ184912A (en) | 2-phenylamino-imidazolines and pharmaceutical compositions | |
| JPS5248674A (en) | Benzisoquinolines and preparation method thereof | |
| JPS52279A (en) | Nebverelaxant and prparation method | |
| JPS5323305A (en) | Powdery oillcontaining composition and making method thereof | |
| JPS5362834A (en) | Pharmaceutical composition and use thereof | |
| PH12590A (en) | 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof | |
| JPS5320433A (en) | Pharmaceutical composition and application | |
| NZ183549A (en) | Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions | |
| PH13130A (en) | Pharmaceutical composition and method |